Renewal of Department of Defense Federal Advisory Committees, 41995-41996 [2014-16883]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 138 / Friday, July 18, 2014 / Notices
information does not seek classified
information or trade secrets.
Respondents will be requested to state
whether any information provided in
response to this information collection
is privileged or confidential commercial
or financial information.
Affected Public: Business or Other
For-Profits; Not-for Profit Institutions.
Frequency: On occasion.
Respondent’s Obligation: Voluntary.
OMB Desk Officer: Ms. Jasmeet
Seehra.
Written comments and
recommendations on the proposed
information collection should be sent to
Ms. Jasmeet Seehra at the Office of
Management and Budget, Desk Officer
for DoD, Room 10236, New Executive
Office Building, Washington, DC 20503.
You may also submit comments,
identified by docket number and title,
by the following method:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
Instructions: All submissions received
must include the agency name, docket
number and title for this Federal
Register document. The general policy
for comments and other submissions
from members of the public is to make
these submissions available for public
viewing on the Internet at https://
www.regulations.gov as they are
received without change, including any
personal identifiers or contact
information.
DOD Clearance Officer: Ms. Patricia
Toppings.
Written requests for copies of the
information collection proposal should
be sent to Ms. Toppings at WHS/ESD
Information Management Division, 4800
Mark Center Drive, East Tower, Suite
02G09, Alexandria, VA 22350–3100.
Dated: July 14, 2014.
Aaron Siegel,
Alternate OSD Federal Register Liaison
Officer, Department of Defense.
[FR Doc. 2014–16884 Filed 7–17–14; 8:45 am]
BILLING CODE 5001–06–P
DEPARTMENT OF DEFENSE
Office of the Secretary
Renewal of Department of Defense
Federal Advisory Committees
DoD.
Renewal of Federal Advisory
Committee.
sroberts on DSK5SPTVN1PROD with NOTICES
AGENCY:
ACTION:
The Department of Defense is
publishing this notice to announce that
it is renewing the charter for the
Uniform Formulary Beneficiary
Advisory Panel (‘‘the Panel’’).
SUMMARY:
VerDate Mar<15>2010
23:20 Jul 17, 2014
Jkt 232001
Jim
Freeman, Advisory Committee
Management Officer for the Department
of Defense, 703–692–5952.
SUPPLEMENTARY INFORMATION: This
Panel’s charter is being renewed under
the provisions of 10 U.S.C. 1074g(c), the
Federal Advisory Committee Act of
1972 (5 U.S.C. Appendix, as amended),
the Government in the Sunshine Act of
1976 (5 U.S.C. 552b) (‘‘the Sunshine
Act’’), and 41 CFR 102–3.50(a).
The Panel is a non-discretionary
Federal advisory committee that shall
provide the Secretary of Defense and the
Deputy Secretary of Defense, through
the Under Secretary of Defense for
Personnel and Readiness (USD(P&R)),
the Assistant Secretary of Defense for
Health Affairs (ASD(HA)), and the
Director, Defense Health Agency,
independent advice and
recommendations on the development
of the uniform formulary. The Secretary
of Defense shall consider the comments
of the Panel before implementing the
uniform formulary or implementing
changes to the uniform formulary.
The Panel shall report to the Secretary
of Defense and the Deputy Secretary of
Defense through the USD(P&R), the
ASD(HA), and the Director, Defense
Health Agency. The USD(P&R) may act
upon the Panel’s advice and
recommendations.
The Department of Defense (DoD),
through the office of the USD(P&R) and
the Defense Health Agency, shall
provide support, as deemed necessary,
for the Panel’s performance, and shall
ensure compliance with the
requirements of the FACA, the
Government in the Sunshine Act of
1976 (5 U.S.C. 552b, as amended) (‘‘the
Sunshine Act’’), governing Federal
statutes and regulations, and established
DoD policies and procedures.
The Panel, pursuant to 10 U.S.C.
1074g(c)(2), shall be comprised of no
more than 15 members. The Panel shall
include members that represent:
a. Non-governmental organizations
and associations that represent the
views and interests of a large number of
eligible covered beneficiaries;
b. Contractors responsible for the
TRICARE retail pharmacy program;
c. Contractors responsible for the
national mail-order pharmacy program;
and
d. TRICARE network providers.
Panel members shall be appointed by
the Secretary of Defense or the Deputy
Secretary of Defense and their
appointments shall be renewed on an
annual basis in accordance with DoD
policies and procedures. Individuals
who are not full-time or permanent partFOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
41995
time Federal employees shall be
appointed as experts or consultants,
pursuant to 5 U.S.C. § 3109, to serve as
special government employee (SGE)
members. Individuals who are full-time
or permanent part-time Federal
employees shall be appointed, pursuant
to 41 CFR 102–3.130(a), to serve as
regular government employee (RGE)
members. Panel members shall serve a
term of service of one-to-four years, and
no member may serve more than two
consecutive terms of service without the
Secretary of Defense or the Deputy
Secretary of Defense approval. This
same term of service limitations also
applies to any DoD authorized
subcommittee.
All new members of the panel are
appointed to provide advice on the basis
of their best judgment without
representing any particular point of
view and a manner that is free from
conflict of interest.
Panel members will serve without
compensation except for reimbursement
of travel and per diem as it pertains to
official business of the Panel.
DoD, when necessary and consistent
with the Panel’s mission and DoD
policies and procedures, may establish
subcommittees, task forces, or working
groups to support the Panel.
Establishment of subcommittees will be
based upon a written determination, to
include terms of reference, by the
Secretary of Defense, the Deputy
Secretary of Defense, or the USD(P&R),
as the Panel’s sponsor.
Such subcommittees shall not work
independently of the chartered Panel,
and shall report all of their
recommendations and advice solely to
the Panel for full and open deliberation
and discussion. Subcommittees, task
forces, or working groups have no
authority to make decisions and
recommendations, verbally or in
writing, on behalf of the Panel. No
subcommittee or any of its members can
update or report, verbally or in writing,
on behalf of the Panel, directly to the
DoD or any Federal officer or employee.
The Secretary of Defense or the
Deputy Secretary of Defense will
appoint subcommittee members to a
term of service of one-to-four years, with
annual renewals, even if the member in
question is already a member of the
Panel. Subcommittee members shall not
serve more than two consecutive terms
of service unless authorized by the
Secretary of Defense or the Deputy
Secretary of Defense.
Subcommittee members, if not fulltime or permanent part-time Federal
employees, will be appointed as experts
or consultants pursuant to 5 U.S.C. 3109
to serve as SGE members. Subcommittee
E:\FR\FM\18JYN1.SGM
18JYN1
sroberts on DSK5SPTVN1PROD with NOTICES
41996
Federal Register / Vol. 79, No. 138 / Friday, July 18, 2014 / Notices
members, who are full-time or
permanent part-time Federal employees,
shall be appointed pursuant to 41 CFR
102–3.130(a) to serve as RGE members.
With the exception of reimbursement of
official travel and per diem related to
the Panel or its subcommittees,
subcommittee members shall serve
without compensation.
All subcommittees operate under the
provisions of FACA, the Sunshine Act,
governing Federal statutes and
regulations, and established DoD
policies and procedures.
The Panel’s Designated Federal
Officer (DFO) shall be a full-time or
permanent part-time DoD employee and
shall be appointed in accordance with
established DoD policies and
procedures.
The Panel’s DFO is required to be in
attendance at all meetings of the Panel
and any subcommittees for the entire
duration of each and every meeting.
However, in the absence of the Panel’s
DFO, a properly approved Alternate
DFO, duly appointed to the Panel
according to established DoD policies
and procedures, shall attend the entire
duration of all meetings of the Panel and
its subcommittees.
The DFO, or the Alternate DFO, shall
call all meetings of the Panel and its
subcommittees; prepare and approve all
meeting agendas; and adjourn any
meeting when the DFO, or the Alternate
DFO, determines adjournment to be in
the public interest or required by
governing regulations or DoD policies
and procedures.
Pursuant to 41 CFR 102–3.105(j) and
102–3.140, the public or interested
organizations may submit written
statements to Uniform Formulary
Beneficiary Advisory Panel membership
about the Panel’s mission and functions.
Written statements may be submitted at
any time or in response to the stated
agenda of planned meeting of the
Uniform Formulary Beneficiary
Advisory Panel.
All written statements shall be
submitted to the DFO for the Uniform
Formulary Beneficiary Advisory Panel,
and this individual will ensure that the
written statements are provided to the
membership for their consideration.
Contact information for the Uniform
Formulary Beneficiary Advisory Panel
DFO can be obtained from the GSA’s
FACA Database—https://
www.facadatabase.gov/.
The DFO, pursuant to 41 CFR 102–
3.150, will announce planned meetings
of the Uniform Formulary Beneficiary
Advisory Panel. The DFO, at that time,
may provide additional guidance on the
submission of written statements that
VerDate Mar<15>2010
23:20 Jul 17, 2014
Jkt 232001
are in response to the stated agenda for
the planned meeting in question.
Dated: July 14, 2014.
Aaron Siegel,
Alternate OSD Federal Register Liaison
Officer, Department of Defense.
[FR Doc. 2014–16883 Filed 7–17–14; 8:45 am]
BILLING CODE 5001–06–P
DEPARTMENT OF DEFENSE
Office of the Secretary
Board of Regents, Uniformed Services
University of the Health Sciences;
Notice of Quarterly Meeting
Uniformed Services University
of the Health Sciences (USU),
Department of Defense.
ACTION: Quarterly meeting notice.
AGENCY:
The Department of Defense is
publishing this notice to announce the
following meeting of the Board of
Regents, Uniformed Services University
of the Health Sciences (‘‘The Board’’).
DATES: Tuesday, August 5, 2014, from
8:00 a.m. to 10:30 a.m. (Open Session)
and 10:45 a.m. to 11:45 a.m. (Closed
Session).
SUMMARY:
Everett Alvarez Jr. Board of
Regents Room (D3001), Uniformed
Services University of the Health
Sciences, 4301 Jones Bridge Road,
Bethesda, Maryland 20814.
FOR FURTHER INFORMATION CONTACT:
Jennifer Nuetzi James, Designated
Federal Officer, 4301 Jones Bridge Road,
D3002, Bethesda, Maryland 20814;
telephone 301–295–3066; email
jennifer.nuetzi-james@usuhs.edu.
SUPPLEMENTARY INFORMATION: This
meeting notice is being published under
the provisions of the Federal Advisory
Committee Act of 1972 (5 U.S.C.,
Appendix, as amended), the
Government in the Sunshine Act of
1976 (5 U.S.C. 552b, as amended), and
41 CFR 102–3.150.
Purpose of the Meeting: The purpose
of the meeting is to review the
operations of USU, particularly the
academic affairs, and provide advice to
the USU President and the Assistant
Secretary of Defense for Health Affairs.
These actions are necessary for the
University to pursue its mission, which
is to provide outstanding healthcare
practitioners and scientists to the
uniformed services, and to obtain
institutional accreditation.
Agenda: The actions that will take
place include the approval of minutes
from the Board Meeting held on May 16,
2014; recommendations regarding the
approval of faculty appointments and
ADDRESSES:
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
promotions; recommendations regarding
the awarding of post-baccalaureate
degrees as follows: Master’s and
doctoral degrees in the biomedical
sciences and public health; Doctor of
Medicine, Ph.D. in Nursing Science,
Master of Science in Nursing; and the
approval of awards and honors. The
USU President will provide a report on
recent actions affecting academic and
operations of the University; a report of
Graduate Medical Education in the
National Capital Region will be
provided; the School of Medicine will
report on matriculation and declination
information and faculty appointment
CV’s; and the USU Inspector General
will provide a quarterly report on open
audits and investigations and will
discuss the expanding role of the Office
of the Inspector General in University
activities. A closed session will be held
to discuss personnel actions and active
investigations.
Meeting Accessibility: Pursuant to
Federal statute and regulations (5 U.S.C.
552b and 41 CFR 102–3.140 through
102–3.165) and the availability of space,
the meeting is open to the public from
8:00 a.m. to 10:30 a.m. Seating is on a
first-come basis. Members of the public
wishing to attend the meeting should
contact Jennifer Nuetzi James at the
address and phone number noted in the
FOR FURTHER INFORMATION CONTACT
section.
Pursuant to 5 U.S.C. 552b(c)(2, 5–7)
the Department of Defense has
determined that the portion of the
meeting from 10:45 a.m. to 11:45 a.m.
shall be closed to the public. The Under
Secretary of Defense (Personnel and
Readiness), in consultation with the
Office of the DoD General Counsel, has
determined in writing that a portion of
the committee’s meeting will be closed
as the discussion will disclose sensitive
personnel information, will include
matters that relate solely to the internal
personnel rules and practices of the
agency, will involve accusing a person
of a crime or censuring an individual,
and may disclose investigatory records
compiled for law enforcement purposes.
Written Statements: Pursuant to 41
CFR 102–3.140, and section 10(a)(3) of
the Federal Advisory Committee Act of
1972, the public or interested
organizations may submit written
comments to the Board about its
approved agenda pertaining to the open
portion of this meeting, or at any time
on the Board’s mission. Individuals
submitting a written statement must
submit their statement to the Designated
Federal Officer at the address listed in
the FOR FURTHER INFORMATION CONTACT
section. If such statement is not received
at least 5 calendar days prior to the
E:\FR\FM\18JYN1.SGM
18JYN1
]]>Agencies
[Federal Register Volume 79, Number 138 (Friday, July 18, 2014)]
[Notices]
[Pages 41995-41996]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-16883]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
Renewal of Department of Defense Federal Advisory Committees
AGENCY: DoD.
ACTION: Renewal of Federal Advisory Committee.
-----------------------------------------------------------------------
SUMMARY: The Department of Defense is publishing this notice to
announce that it is renewing the charter for the Uniform Formulary
Beneficiary Advisory Panel (``the Panel'').
FOR FURTHER INFORMATION CONTACT: Jim Freeman, Advisory Committee
Management Officer for the Department of Defense, 703-692-5952.
SUPPLEMENTARY INFORMATION: This Panel's charter is being renewed under
the provisions of 10 U.S.C. 1074g(c), the Federal Advisory Committee
Act of 1972 (5 U.S.C. Appendix, as amended), the Government in the
Sunshine Act of 1976 (5 U.S.C. 552b) (``the Sunshine Act''), and 41 CFR
102-3.50(a).
The Panel is a non-discretionary Federal advisory committee that
shall provide the Secretary of Defense and the Deputy Secretary of
Defense, through the Under Secretary of Defense for Personnel and
Readiness (USD(P&R)), the Assistant Secretary of Defense for Health
Affairs (ASD(HA)), and the Director, Defense Health Agency, independent
advice and recommendations on the development of the uniform formulary.
The Secretary of Defense shall consider the comments of the Panel
before implementing the uniform formulary or implementing changes to
the uniform formulary.
The Panel shall report to the Secretary of Defense and the Deputy
Secretary of Defense through the USD(P&R), the ASD(HA), and the
Director, Defense Health Agency. The USD(P&R) may act upon the Panel's
advice and recommendations.
The Department of Defense (DoD), through the office of the USD(P&R)
and the Defense Health Agency, shall provide support, as deemed
necessary, for the Panel's performance, and shall ensure compliance
with the requirements of the FACA, the Government in the Sunshine Act
of 1976 (5 U.S.C. 552b, as amended) (``the Sunshine Act''), governing
Federal statutes and regulations, and established DoD policies and
procedures.
The Panel, pursuant to 10 U.S.C. 1074g(c)(2), shall be comprised of
no more than 15 members. The Panel shall include members that
represent:
a. Non-governmental organizations and associations that represent
the views and interests of a large number of eligible covered
beneficiaries;
b. Contractors responsible for the TRICARE retail pharmacy program;
c. Contractors responsible for the national mail-order pharmacy
program; and
d. TRICARE network providers.
Panel members shall be appointed by the Secretary of Defense or the
Deputy Secretary of Defense and their appointments shall be renewed on
an annual basis in accordance with DoD policies and procedures.
Individuals who are not full-time or permanent part-time Federal
employees shall be appointed as experts or consultants, pursuant to 5
U.S.C. Sec. 3109, to serve as special government employee (SGE)
members. Individuals who are full-time or permanent part-time Federal
employees shall be appointed, pursuant to 41 CFR 102-3.130(a), to serve
as regular government employee (RGE) members. Panel members shall serve
a term of service of one-to-four years, and no member may serve more
than two consecutive terms of service without the Secretary of Defense
or the Deputy Secretary of Defense approval. This same term of service
limitations also applies to any DoD authorized subcommittee.
All new members of the panel are appointed to provide advice on the
basis of their best judgment without representing any particular point
of view and a manner that is free from conflict of interest.
Panel members will serve without compensation except for
reimbursement of travel and per diem as it pertains to official
business of the Panel.
DoD, when necessary and consistent with the Panel's mission and DoD
policies and procedures, may establish subcommittees, task forces, or
working groups to support the Panel. Establishment of subcommittees
will be based upon a written determination, to include terms of
reference, by the Secretary of Defense, the Deputy Secretary of
Defense, or the USD(P&R), as the Panel's sponsor.
Such subcommittees shall not work independently of the chartered
Panel, and shall report all of their recommendations and advice solely
to the Panel for full and open deliberation and discussion.
Subcommittees, task forces, or working groups have no authority to make
decisions and recommendations, verbally or in writing, on behalf of the
Panel. No subcommittee or any of its members can update or report,
verbally or in writing, on behalf of the Panel, directly to the DoD or
any Federal officer or employee.
The Secretary of Defense or the Deputy Secretary of Defense will
appoint subcommittee members to a term of service of one-to-four years,
with annual renewals, even if the member in question is already a
member of the Panel. Subcommittee members shall not serve more than two
consecutive terms of service unless authorized by the Secretary of
Defense or the Deputy Secretary of Defense.
Subcommittee members, if not full-time or permanent part-time
Federal employees, will be appointed as experts or consultants pursuant
to 5 U.S.C. 3109 to serve as SGE members. Subcommittee
[[Page 41996]]
members, who are full-time or permanent part-time Federal employees,
shall be appointed pursuant to 41 CFR 102-3.130(a) to serve as RGE
members. With the exception of reimbursement of official travel and per
diem related to the Panel or its subcommittees, subcommittee members
shall serve without compensation.
All subcommittees operate under the provisions of FACA, the
Sunshine Act, governing Federal statutes and regulations, and
established DoD policies and procedures.
The Panel's Designated Federal Officer (DFO) shall be a full-time
or permanent part-time DoD employee and shall be appointed in
accordance with established DoD policies and procedures.
The Panel's DFO is required to be in attendance at all meetings of
the Panel and any subcommittees for the entire duration of each and
every meeting. However, in the absence of the Panel's DFO, a properly
approved Alternate DFO, duly appointed to the Panel according to
established DoD policies and procedures, shall attend the entire
duration of all meetings of the Panel and its subcommittees.
The DFO, or the Alternate DFO, shall call all meetings of the Panel
and its subcommittees; prepare and approve all meeting agendas; and
adjourn any meeting when the DFO, or the Alternate DFO, determines
adjournment to be in the public interest or required by governing
regulations or DoD policies and procedures.
Pursuant to 41 CFR 102-3.105(j) and 102-3.140, the public or
interested organizations may submit written statements to Uniform
Formulary Beneficiary Advisory Panel membership about the Panel's
mission and functions. Written statements may be submitted at any time
or in response to the stated agenda of planned meeting of the Uniform
Formulary Beneficiary Advisory Panel.
All written statements shall be submitted to the DFO for the
Uniform Formulary Beneficiary Advisory Panel, and this individual will
ensure that the written statements are provided to the membership for
their consideration. Contact information for the Uniform Formulary
Beneficiary Advisory Panel DFO can be obtained from the GSA's FACA
Database--https://www.facadatabase.gov/.
The DFO, pursuant to 41 CFR 102-3.150, will announce planned
meetings of the Uniform Formulary Beneficiary Advisory Panel. The DFO,
at that time, may provide additional guidance on the submission of
written statements that are in response to the stated agenda for the
planned meeting in question.
Dated: July 14, 2014.
Aaron Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2014-16883 Filed 7-17-14; 8:45 am]
BILLING CODE 5001-06-P
